A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction

Area of Science:

• Neuroscience
• Psychiatry
• Molecular Biology

Background:

• Dopaminergic system overactivity is linked to schizophrenia.
• GABAergic control of dopamine is critical for brain function.
• GABA(A) receptors, particularly the alpha3 subunit, play a role in regulating neuronal activity.

Purpose of the Study:

• To investigate the role of alpha3-containing GABA(A) receptors in dopaminergic function and sensorimotor gating.
• To assess the impact of disrupting the alpha3 subunit of the GABA(A) receptor on brain function and behavior.
• To explore potential therapeutic targets for psychiatric conditions like schizophrenia.

Main Methods:

• Generation of alpha3 knockout (alpha3KO) mice lacking the alpha3 subunit of the GABA(A) receptor.
• Behavioral testing including elevated-plus-maze and acoustic startle reflex (prepulse inhibition).
• Electrophysiological recordings from midbrain dopamine neurons.
• Pharmacological manipulation with haloperidol and amphetamine.

Main Results:

• alpha3KO mice showed no gross developmental or morphological brain abnormalities.
• GABA-induced currents in dopamine neurons were reduced in alpha3KO mice.
• Prepulse inhibition of the acoustic startle reflex was significantly impaired in alpha3KO mice, indicating a sensorimotor gating deficit.
• This deficit was reversed by haloperidol treatment.
• Anxiety-related behaviors and diazepam's anxiolytic effect were unaffected.

Conclusions:

• Absence of alpha3-subunit-containing GABA(A) receptors induces a hyperdopaminergic phenotype.
• A deficit in sensorimotor gating is a key feature of alpha3KO mice, relevant to psychiatric disorders.
• Targeting alpha3-containing GABA(A) receptors may offer a novel therapeutic strategy for sensorimotor gating deficits in schizophrenia and other conditions.